COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- Regulation of food supplements in Algeria: Current situation, issues, and perspectives.
- Comparison of lifestyle patterns and body weight management practices between normal weight and obese female university students (Riyadh – Saudi Arabia)
- Abstract Book: First International Conference on Food Security and Sustainable Agri-food Technologies – ICFSSAT 2025
- Predatory journals and publishers at a glance: Take apart or take over?
- Physicochemical quality assessment of Brazilian frozen beef imported into Algeria
- Metabolic syndrome components correlation with colorectal neoplasms: A systematic review and a meta-analysis
- Comparison of five solvents in the extraction of phenolic antioxidants from pomegranate (Punica granatum L.) peel
- Association of obesity with the lower limbs osteoarthritis in a community of women from El Jadida province in Morocco
- Statistical study of the relationship between hyperuricemia, dyslipidemia and type 2 diabetes in rural population of Tizi-Ouzou, Algeria
- In vitro, antioxidant activities of aqueous and methanol roselle (Hibiscus sabdariffa) calyces extracts from two localities in Cameroon
You may also start an advanced similarity search for this article.

NAJFNR is licensed under